
    
      The study is a prospective, observational, multicenter clinical trial to be conducted in the
      internal medicine, rheumatology and virology departments of Military Hospital of Tunis. After
      obtaining informed consent from the patient, the investigator will perform an inclusion visit
      made of a patient interview and performing blood sample to search for IgG and anti-SARS IgM
      CoV2.

      Patients with IgM-like antibodies will have an RT-PCR test for active infection. If the study
      participants will be diagnosed with COVID-19 positive during the study period, the attending
      physician is entitled to decide on their management based on the severity of the clinical
      status.
    
  